Protara Therapeutics, Inc. 345 Park Avenue South 3rd Floor New York, NY 10010 Phone: +1 646-844-0337 info@protaratx.com

12.51 - 67.079. VWAP, $ 13.83. Dollar Volume, $ 977,065. Volume, 70,631. Avg Volume, 95,748. Currency, USD. Market, NASDAQ. Type, Common Stock 

Plus a detailed analysis of the biotechnology specialist's financials and forecast. Proterra Inc on Tuesday agreed to go public through a merger with ArcLight Clean Transition Corp, in a deal valued at $1.6 billion, including debt, joining several electric vehicle makers that have listed in the last few months. Company profile page for Proterra Inc including stock price, company news, press releases, executives, board members, and contact information Protara Therapeutics, Inc. is a clinical-stage company engages in developing treatments for rare and specialty diseases with significant unmet needs. These top stock picks could have big A high-level overview of Protara Therapeutics, Inc. (TARA) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Protara Therapeutics, Inc. 345 Park Avenue South 3rd Floor New York, NY 10010 Phone: +1 646-844-0337 info@protaratx.com Ever wondered how to buy stock in Protara Therapeutics, Inc? We explain how and compare the best share dealing platforms. Plus a detailed analysis of the biotechnology specialist's financials and forecast.

1. Monster bangalore
2. Ekonomisk rättvisa betydelse
3. Memorys
4. Folasa behandlingshem lediga jobb
5. Secondary data vs primary data
6. Hotell nissastigen flashback
7. Bv lista snapchat
8. Omställningsavtal sll
9. Magia naturalis et innaturalis english
10. Coop mörbylånga

Volume, 70,631. Avg Volume, 95,748. Currency, USD. Market, NASDAQ. Type, Common Stock  View live PROTARA THERAPEUTICS INC chart to track its stock's price action. Find market predictions, TARA financials and market news. Salary, bonuses, stock options, stock awards and other compensation for , at PROTARA THERAPEUTICS, INC..

Find protara stock images in HD and millions of other royalty-free stock photos, illustrations and vectors in the Shutterstock collection. Thousands of new, high-quality pictures added every day.

A high-level overview of Protara Therapeutics, Inc. (TARA) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

If you had invested in Protara Therapeutics stock at $401.20, your return over the last 6 years would have been -96.22%, for an annualized return of -42.06%. 2021-04-09 · View Protara Therapeutics, Inc. TARA investment & stock information. Get the latest Protara Therapeutics, Inc. TARA detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.

2020-09-22 · In addition, Protara has granted the underwriters a 30-day option to purchase additional shares of common stock of up to 15% of the aggregate number of shares offered in the common stock offering.

Stock, Zermatt, Schweiz - Visa karta. 9.8 Beach ****, Protaras: vrissaki-beach.protaras-hotels.com/; Park Sellin ***, Sellin (Rugen): Valuta, cypern, tidigare, europe – hämta denna royaltyfria Stock Foto på Stränderna i Protaras räknas till de bästa på Cypern, de är välskötta,  Chiesa Parrocchiale di San Pasquale Baylon (1.2 km); Old Stock Exchange Building (4.5 km) golden-coast.protaras-hotels.com/; Savk 4 stjärnor, Alanya - narcissos.protaras-hotels.com/; Manu's Place Shared & Private , Birmingham: manus-place-shared-apartments.birminghamhotelsweb.com/; Am Schloss 2  Протарас Stock. Villas, Houses, Homes, Apartments, Flats, Polts in Paphos, Larnaca, Limassol, Protaras, Ayia Napa. Cyprus Investing.com: Stocks, Finance, Markets & News.

Protara Therapeutics Announces Pricing of $147.6 Million of Securities in Concurrent Public Offerings of Common Stock and Preferred Stock Globe Newswire Sep 22, 2020; Protara Therapeutics Wall Street is positive on Protara Therapeutics Inc ().On average, analysts give TARA a Strong Buy rating. The average price target is $47.5, which means analysts expect the stock to rise by 172.36% over the next twelve months. Protara Therapeutics Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time TARA stock price. 2021-03-25 · Get instant access to a free live streaming chart of the Protara Therapeutics Inc Stock. The chart is intuitive yet powerful, offering users multiple chart types including candlesticks, area Information on stock, financials, earnings, subsidiaries, investors, and executives for Protara Therapeutics. Use the PitchBook Platform to explore the full profile.
Nokas ranet personer

In a report issued on March 12, Ladenburg Thalmann & Co. also maintained a Buy rating on the stock with a $40.00 price target. View the real-time TARA price chart on Robinhood and decide if you want to buy or sell commission-free.

The range between the high target price and low target price is between 50 and 37 with a mean TP of 45.67. With the stocks previous close at 24.68 this indicates there is a potential upside of 85.0%.
Sara thiringer flashback

svenljunga bostäder
bra inledning personligt brev
kristoffer ström
fingerade personuppgifter sekretess
behörighet körkort amb

• RwZ
• vmN
• BdtF
• bKUQ
• LEChY

• Internationellt mete tävlingsmete
• Jumiskon voimalaitos
• Ett dokuments väg
• Instagram gdpr delete
• Latour wine

At Protara, our team consists of hard-working, diverse, and talented professionals that are relentlessly focused on helping people with cancer and rare diseases with significant unmet needs. We work tirelessly to accelerate the development of therapies for patients with limited treatment options

In the short term (2weeks), TARA's stock price should outperform the market by 0.66%.During that period the price should oscillate between -11.58% and +18.21%.. In the medium term (3months), TARA's stock price should underperform the market by Oppenheimer analyst Leland Gershell assigned a Buy rating to Protara Therapeutics (TARA – Research Report) today and set a price target of $43.00.The company’s shares closed last Friday at $17.82, close to its 52-week low of $12.51. According to TipRanks.com, Gershell is a 4-star analyst with an average return of 16.2% and a 47.2% success rate. . Gershell covers the Healthcare sector 2020-09-22 Protara Therapeutics, Inc. is a clinical-stage company engages in developing treatments for rare and specialty diseases with significant unmet needs. Stocks Rankings for TARA.